Aryavaan Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 07-07-2024
- Paid Up Capital ₹ 0.20 M
as on 07-07-2024
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -25.00%
(FY 2021)
- Profit -3.68%
(FY 2021)
- Ebitda -12.12%
(FY 2021)
- Net Worth -63.80%
(FY 2021)
- Total Assets 55.79%
(FY 2021)
About Aryavaan Pharmaceuticals
The Corporate was formerly known as Vastu Shining Builders Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Krishnakumar Agrawal, Anirudh Agrawal, and Anurag Agrawal serve as directors at the Company.
- CIN/LLPIN
U24100GA2004PTC007040
- Company No.
007040
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Sep 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
South Goa, Goa, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Aryavaan Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anirudh Agrawal  | Director | 16-Mar-2012 | Current |
| Krishnakumar Agrawal | Director | 16-Mar-2012 | Current |
| Anurag Agrawal | Director | 16-Mar-2012 | Current |
Financial Performance and Corporate Structure Insights of Aryavaan Pharmaceuticals.
Aryavaan Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 25% decrease. The company also saw a slight decrease in profitability, with a 3.68% decrease in profit. The company's net worth observed a substantial decline by a decrease of 63.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aryavaan Pharmaceuticals?
In 2020, Aryavaan Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kayji Real Estate Private Limited.Active 48 years 6 monthsKrishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
Dci Pharmaceuticals Private LimitedActive 48 years 11 monthsKrishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
Agrawal Minerals (Goa) Private LimitedActive 58 years 1 monthKrishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
- Agrawal Medicaments Private LimitedActive 12 years 12 days
Krishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
- Medizest Pharmaceuticals Private LimitedActive 37 years 5 months
Krishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
- Tyresoles Goa Private LimitedActive 59 years 6 months
Krishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aryavaan Pharmaceuticals?
Unlock and access historical data on people associated with Aryavaan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aryavaan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aryavaan Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
